difference bet. diclofenac na and diclofenac k
Diclofenac sodium and diclofenac potassium are both salts of the same active molecule (diclofenac), but differ mainly in their onset of action and formulation uses. Diclofenac K is faster-acting due to better solubility, while diclofenac Na is slower and suited for sustained effects.
Searching sources...
Reading File
Searching the Web
diclofenac sodium vs diclofenac potassium pharmacokinetics clinical differences
Finding Sources
Reading File
Here is a clear, side-by-side breakdown of the two salts:
Diclofenac Sodium vs. Diclofenac Potassium
Both are salts of the same active molecule - diclofenac - a phenylacetic acid derivative and relatively non-selective COX inhibitor. The difference lies in the counterion, which affects solubility, formulation, onset of action, and clinical use.
Key Differences at a Glance
| Property | Diclofenac Sodium (Na) | Diclofenac Potassium (K) |
|---|---|---|
| Salt / Ion | Sodium salt | Potassium salt |
| Water solubility | Lower | Higher |
| Tablet coating | Usually enteric-coated | Usually immediate-release (uncoated) |
| Onset of action | 30-60 min (oral); peak plasma ~2-4 hours | 15-30 min; peak plasma ~30-54 min |
| Duration | Longer, sustained | Shorter per dose |
| Typical dose | 50 mg TDS or 75 mg BD (oral); SR 100 mg OD | 25-50 mg TDS |
| Best suited for | Chronic inflammatory conditions (OA, RA, AS) | Acute pain - dental, dysmenorrhoea, migraine, gout, post-op |
| Topical/ophthalmic | 0.1% ophthalmic solution (Voltaren), 1% and 3% gels | Primarily oral |
| GI side effects | Enteric coating reduces immediate GI irritation | Faster absorption; GI risk if not taken with food |
| Common brands | Voveran, Voltaren (SR/tablets) | Cataflam, Cambia |
| OTC availability | Prescription in most countries | Was OTC in some markets; withdrawn due to CV concerns |
Why the Difference Matters Clinically
-
Speed vs. Sustained effect: The potassium salt is more water-soluble, so it dissolves and absorbs faster. The Pharmaceutical Journal notes peak plasma levels are reached in 30-54 minutes with diclofenac K vs. 2-4 hours with enteric-coated diclofenac Na.
-
Same total exposure: The area under the curve (AUC) is essentially the same - you get the same total drug, just at different speeds. The mechanism of action (COX inhibition, prostaglandin suppression) is identical once absorbed.
-
Enteric coating on Na: Diclofenac sodium tablets are often enteric-coated specifically to slow dissolution, protect the stomach, and allow timed release - further delaying onset but improving GI tolerability for long-term use.
-
Post-op / acute pain: NIHR evidence indicates a single dose of diclofenac potassium 50 mg is more effective for postoperative pain compared to enteric-coated diclofenac sodium, because of earlier and higher initial plasma concentration.
-
Synovial fluid kinetics: Peak diclofenac levels in synovial fluid lag ~2-4 hours behind plasma peaks. For chronic arthritis, diclofenac Na's slower plasma rise still achieves effective synovial levels - making the speed difference largely irrelevant for regular dosing.
-
Hepatotoxicity: Both forms share the same risk - diclofenac causes aminotransferase elevation more commonly than other NSAIDs (Katzung's Basic and Clinical Pharmacology, 16th Ed).
-
Potassium load: The potassium content in a 50 mg diclofenac K tablet is very small (~4.7 mg of K+) - not clinically significant in most patients. However, patients with renal impairment or those on ACE inhibitors / K-sparing diuretics should avoid all oral NSAIDs regardless.
Summary
- Choose diclofenac K when rapid analgesia is needed (dysmenorrhoea, migraine, acute dental/gout pain, post-op).
- Choose diclofenac Na for chronic inflammatory conditions requiring sustained, round-the-clock anti-inflammatory coverage.
- Both carry the same class warnings: GI ulceration, cardiovascular risk, nephrotoxicity, and hepatotoxicity.
dose
Here are the standard doses for both salts:
Diclofenac Dosing
Diclofenac Sodium (Na)
| Formulation | Dose | Frequency | Max Daily Dose |
|---|---|---|---|
| Immediate-release tablet | 50 mg | TDS (3x/day) | 150 mg/day |
| Sustained-release (SR/XR) | 75 mg | BD (2x/day) | 150 mg/day |
| Sustained-release (SR) | 100 mg | OD (1x/day) | 150 mg/day |
| Suppository (rectal) | 50-100 mg | OD-BD | 150 mg/day |
| Topical gel (1%) | 2-4 g applied | Q6-8h | - |
| Ophthalmic (0.1%) | 1 drop | QID | - |
| IM injection | 75 mg | OD (max 2 days) | 150 mg/day |
Diclofenac Potassium (K)
| Formulation | Dose | Frequency | Max Daily Dose |
|---|---|---|---|
| Immediate-release tablet | 25-50 mg | TDS (3x/day) | 150 mg/day |
| Acute pain (single dose) | 50 mg | PRN | 150 mg/day |
| Powder for oral solution (Cambia) | 50 mg | Single dose for migraine | 50 mg |
Pediatric Dosing (Diclofenac)
- 1-14 years: 1-3 mg/kg/day in divided doses
- JRA: up to 3 mg/kg/day
Special Populations
| Condition | Recommendation |
|---|---|
| Renal impairment | Avoid if GFR < 30 mL/min |
| Hepatic impairment | Use with caution; monitor LFTs |
| Elderly | Start at lowest effective dose; use shortest duration |
| Pregnancy | Avoid after 20 weeks; contraindicated in 3rd trimester |
Key point: The maximum dose is the same (150 mg/day) for both salts - the difference is only in how quickly each dose acts, not in total daily dosage. Always take with food or milk to reduce GI irritation.
This is a shared conversation. Sign in to Orris to start your own chat.